CBD Life Sciences Inc. CBDL
0.00 USD 0.00 (+0.00%)
Nov 10, 2026, 12:47 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.0005
- YTD
- -50.00%
- 1 year
- 0.00%
News
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by:…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Patches The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by:…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces Our Collection of Adaptogenic Mushroom Products The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising demand for immunity-boosting, plant-based, and wellness products.…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces Smoking Scholars Bronx Dispensary as Major Distributor for High-Demand Dubai Mushroom Chocolate With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR, this strategic Bronx, New York distribution expansion positions CBDL to…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Expands Into JFK Airport Through Landmark Mother Earth Juice Bar Partnership in New York With the global pain management market projected to exceed $110 billion by 2030 and hemp-derived topical products continuing to post double-digit annual growth, CBD Life Sciences is accelerating its…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Secures Exclusive Launch of New Anti-Inflammatory "Soothe Gel" Across Two Red Hots Spa Locations in New York With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.…
accessnewswire.com CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition. SCOTTSDALE, ARIZONA…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar" Dubai's luxury chocolate market-valued at over $1.5 billion and growing 6.8% annually-meets the $35 billion global mushroom supplement boom, creating a major new revenue stream for CBDL. SCOTTSDALE,…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division Strong consumer demand and rapid market adoption drive CBDL's beverage expansion as top-selling CBD Lemonade, Raspberry Lemonade, and Lavender Lemonade hit the shelves of Smoking Scholars in New York…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025 The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration "A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and set the stage for explosive industry-wide growth." SCOTTSDALE,…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ / ACCESS Newswire / August 5, 2025 / CBD Life Sciences Inc.…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of…
accessnewswire.com CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged,…
accessnewswire.com CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025 Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday 
benzinga.com Stocks That Hit 52-Week Lows On Friday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Fell Through 52-Week Lows Wednesday